| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |